We measured the serum levels of adiponectin, routine lipid profiles, and free carnitine and acylcarnitine profiles in 167 patients undergoing HD to investigate the relationship between these lipid markers and erythropoietic status, indicated by reticulocyte count and ERI, to obtain novel evidence for the optimal management of anaemia of CKD. The gene discussed is ADIPOQ; the disease is anemia.